(Q28322527)

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

25 October 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

25 October 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

25 October 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

25 October 2022

author name string

N. A. Soter

1

1 reference

Europe PubMed Central

PubMed publication ID

1672136

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1672136

full work available at URL

25 October 2022

language of work or name

English

0 references

publication date

March 1991

0 references

https://api.elsevier.com/content/article/PII:S0022202X9190149K?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

https://api.elsevier.com/content/article/PII:S0022202X9190149K?httpAccept=text/plain

25 October 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Journal of Investigative Dermatology

25 October 2022

published in

0 references

volume

96

0 references

issue

3

0 references

page(s)

32S-38S; discussion 38S-39S

0 references

cites work

Urticaria pigmentosa; mastocytosis; a consideration of various manifestations

1

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases

25 October 2022

7

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Urticaria Pigmentosa Discordant in Identical Twins

25 October 2022

8

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Uniovular twins discordant for cutaneous mastocytosis

25 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Diffuse cutaneous mastocytosis in mother and daughter

25 October 2022

12

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

SYSTEMIC MAST CELL DISEASE.

25 October 2022

15

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

THE MASTOCYTOSIS SYNDROME: CLINICAL AND BIOLOGICAL STUDIES

25 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Systemic mast cell disease: a clinical and hematopathologic study of 26 cases

25 October 2022

18

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Systemic mastocytosis. Extracutaneous manifestations.

25 October 2022

19

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Tissue mast cells in health and disease.

25 October 2022

20

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope

25 October 2022

22

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis

25 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

25 October 2022

Bullous mastocytosis

24

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Bullous urticardia pigmentosa

25 October 2022

25

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Bone marrow findings in adult patients with urticaria pigmentosa

25 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Adult-onset urticaria pigmentosa and systemic mast cell disease

25 October 2022

28

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Urticaria pigmentosa appearing as a solitary nodular lesion

25 October 2022

29

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Solitary Mastocytosis (Urticaria Pigmentosa)

25 October 2022

30

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Course of Urticaria Pigmentosa in Children

25 October 2022

31

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Generalized flushing of the skin with urticaria pigmentosa

25 October 2022

32

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Pseudoxanthomatous mastocytosis

25 October 2022

33

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Bullous mastocytosis: diffuse cutaneous mastocytosis with extensive blisters mimicking scalded skin syndrome or erythema multiforme

25 October 2022

36

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Cutaneous mastocytosis with bleeding: probable heparin effect

25 October 2022

37

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Diffuse cutaneous mastocytosis, 22 years on

25 October 2022

39

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Mast cell infiltrates of the skin and the mastocytosis syndrome

25 October 2022

45

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Comparative Ultrastructural Study of Mast Cells in Mastocytoma and Mastocytosis

25 October 2022

46

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Ultrastructural features of mast cells in systemic mastocytosis

25 October 2022

47

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Ultrastructural morphometric analysis of lesional skin: mast cells from patients with systemic and nonsystemic mastocytosis

25 October 2022

48

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

In vitro functional reactivities of cutaneous mast cells from patients with mastocytosis

25 October 2022

49

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

An Electron Microscopic Study of the Degranulation of Mast Cell Granules in Urticaria Pigmentosa*

25 October 2022

51

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

The mast cells: distribution and morphology

25 October 2022

54

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders

25 October 2022

56

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies

25 October 2022

58

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Mast cells in cutaneous mastocytosis: accumulation of the MCTC type

25 October 2022

59

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

THE LEUKOCYTIC RESPONSE TO ASEPTIC INFLAMMATION IN URTICARIA PIGMENTOSA

25 October 2022

60

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Adult mastocytosis: an immunophenotypic and flow-cytometric investigation

25 October 2022

61

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Analysis of plasma histamine levels in patients with mast cell disorders

25 October 2022

62

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

25 October 2022

63

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Analysis of the wheal-and-flare reactions that follow the intradermal injection of histamine and morphine in adults with recurrent, unexplained anaphylaxis and systemic mastocytosis

25 October 2022

64

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes

25 October 2022

65

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis

25 October 2022

66

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Identification of sulfated mucopolysaccharides including heparin in the lesional skin of a patient with mastocytosis

25 October 2022

67

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Oral disodium cromoglycate in the treatment of systemic mastocytosis

25 October 2022

68

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa

25 October 2022

69

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites

25 October 2022

70

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Metabolic fate of endogenously synthesized prostaglandin D2 in a human female with mastocytosis

25 October 2022

71

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Urinary sulphatase activity in mastocytosis

25 October 2022

74

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Anaphylaxis after hymenoptera stings in three patients with urticaria pigmentosa

25 October 2022

75

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial

25 October 2022

76

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate

25 October 2022

77

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Bullous urticaria pigmentosa (cutaneous mastocytosis) and sodium cromoglycate therapy

25 October 2022

78

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Treatment of bullous mastocytosis with disodium cromoglycate

25 October 2022

79

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Cromolyn sodium in the management of systemic mastocytosis

25 October 2022

80

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

A Double-Blind Cross-Over Study of the Effect of Ketotifen in Urticaria pigmentosa

25 October 2022

82

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Urticaria pigmentosa responsive to nifedipine

25 October 2022

83

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Treatment of adult systemic mastocytosis with a PAF-acether antagonist BN52063

25 October 2022

84

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

PUVA-treatment of urticaria pigmentosa

25 October 2022

85

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa

25 October 2022

86

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations

25 October 2022

87

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Trioxsalen baths plus UV-A in the treatment of lichen planus and urticaria pigmentosa

25 October 2022

88

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

Treatment of urticaria pigmentosa with corticosteroids.

25 October 2022

89

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12468973

25 October 2022

Identifiers